🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Adam I. Riker

Adam I. Riker

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma”.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002478

N/A

4.0DataRank · unranked

140 citations

Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl +24 more

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer

Women s Health Reports(2020)10.1089/whr.2020.0037

N/A

0DataRank · unranked

10 citations

Alexandra A. Giardina, Maryl Wright, Steven Elliott, Michelle Marie Loch, Khoa Nguyen +11 more

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

Clinical & Translational Oncology(2021)10.1007/s12094-021-02677-8

N/A

0DataRank · unranked

22 citations

Tiffany Chang, Maryl Wright, Hope E. Burks, S G Elliott, Rachel A. Sabol +28 more

Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti–PD-L1 Immunotherapy

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0934

N/A

0DataRank · unranked

10 citations

Hao Cheng, Dorota Wyczechowska, Qingzhao Yu, Li Li, Augusto C. Ochoa +3 more

Data from Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens

(2023)10.1158/0008-5472.c.6500703

N/A

0DataRank · unranked

0 citations

Liqin Zheng, Ratika Srivastava, Cruz Velasco‐Gonzalez, Adam I. Riker, Svetomir N. Markovic +2 more

Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer

Communications Medicine(2025)10.1038/s43856-025-01024-0

N/A

0DataRank · unranked

6 citations

Audrey Limb, Valerie Hennes, Andrés Rivera, Rafael Nevarez, Anand Kolatkar +9 more

Sulindac sulfide suppresses oncogenic transformation through let-7b-mediated repression of K-Ras signaling

Cell Death Discovery(2025)10.1038/s41420-025-02858-2

N/A

0DataRank · unranked

1 citations

Ruixia Ma, Bin Yi, Adam I. Riker, Yaguang Xi, Zhipin Liang

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

PLoS ONE(2020)10.1371/journal.pone.0226464

N/A

0DataRank · unranked

18 citations

Margarite D. Matossian, Steven Elliott, Hope E. Burks, Rachel A. Sabol, Deniz A. Uçar +11 more

Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.11.659159

N/A

0DataRank · unranked

0 citations

Ruixia Ma, Xin Zhang, Li Li, Adam I. Riker, Yaguang Xi +1 more